The Rotavirus Vaccine Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the rotavirus vaccine has seen significant growth recently. It is projected to increase from $9.18 billion in 2024 to $10.14 billion in 2025, with a compound annual growth rate (CAGR) of 10.5%.
The Rotavirus Vaccine Global Market is projected to expand to a size of $14.96 billion in 2029, with a compound annual growth rate (CAGR) of 10.2%.
Download Your Free Sample of the 2025 Rotavirus Vaccine Market Report and Uncover Key Trends Now!The key drivers in the rotavirus vaccine market are:
• Rising birth rates globally
• Expansion of vaccination programs
• Increased focus on preventive healthcare
• Government policies and funding supporting vaccination.
The rotavirus vaccine market covered in this report is segmented –
1) By Type: Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Other Types
2) By Application: Adult, Pediatric
3) By End Users: Hospitals, Clinics, Academic Research
Subsegments:
1) By Rotarix: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
2) By RotaTeq: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
3) By Rotavac: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
4) By Rotavin-M1: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
5) By Lanzhou Lamb: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
6) By Other Types: Emerging Rotavirus Vaccines, Combination Vaccines, Region-Specific Vaccines
The key trends in the rotavirus vaccine market are:
• Vaccine technology advancements are a defining trend.
• Innovations in oral-dosing technologies are notably influencing the market.
• Improved vaccine formulations are shaping the future of the rotavirus vaccine market.
• The integration of digital health in vaccination programs is emerging as a significant trend.
Major players in the rotavirus vaccine market are:
• Merck & Co. Inc.
• Sanofi S.A.
• Abbott Laboratories
• GlaxoSmithKline plc
• Daiichi Sankyo Company Limited
• Serum Institute of India Private Limited
• Sinovac Biotech Ltd.
• SK Chemicals Co Ltd.
• Bharat Biotech International Limited
• Walvax Biotechnology Co. Ltd.
• Indian Immunologicals Limited
• PT Bio Farma
• KFF Inc.
• Panacea Biotec Limited
• Sanyou Biopharmaceuticals Co. Ltd.
• Inovio Pharmaceuticals Inc.
• Hilleman Laboratories Private Limited
• China National Biotec Group Corporation
• Vabiotech
• Lanzhou Institute of Biological Products Co. Ltd.
• Nuvonis Pharmaceuticals Inc.
• Chengdu Institute of Biological Products Co. Ltd
North America was the largest region in the rotavirus vaccine market in 2024